Stacy Reese, Associate PRA Director at AstraZeneca, speaking on “Managing the Risks Associated with Online Discussions” at CBI’s 8th Annual Forum on eMarketing for the Pharmaceutical Industry noted that when the FDA is doing more than pharma companies with social media, “we need to figure out how to get in there.”
But Erik van der Zijden, author of an article to be published in the April 2009 issue of Pharma Marketing News (see preview here), thinks pharmaceutical companies are socially challenged.
In fact, many pharmaceutical marketers may have this view of the challenge posed by social media compared to that of Internet 1.0:
